212 related articles for article (PubMed ID: 2894492)
1. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.
Vathenen AS; Knox AJ; Higgins BG; Britton JR; Tattersfield AE
Lancet; 1988 Mar; 1(8585):554-8. PubMed ID: 2894492
[TBL] [Abstract][Full Text] [Related]
2. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
Wong CS; Wahedna I; Pavord ID; Tattersfield AE
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
[TBL] [Abstract][Full Text] [Related]
3. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
4. Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline.
Egbagbe E; Pavord ID; Wilding P; Thompson-Coon J; Tattersfield AE
Thorax; 1997 Mar; 52(3):239-43. PubMed ID: 9093339
[TBL] [Abstract][Full Text] [Related]
5. Effect of regular terbutaline on the airway response to inhaled budesonide.
Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
7. Duration of action of inhaled terbutaline at two different doses and of albuterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in asthmatic subjects.
Malo JL; Ghezzo H; Trudeau C; Cartier A; Morris J
Am Rev Respir Dis; 1989 Sep; 140(3):817-21. PubMed ID: 2782749
[TBL] [Abstract][Full Text] [Related]
8. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
de Jong JW; Koëter GH; van der Mark TW; Postma DS
Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
[TBL] [Abstract][Full Text] [Related]
9. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.
Kraan J; Koëter GH; vd Mark TW; Sluiter HJ; de Vries K
J Allergy Clin Immunol; 1985 Oct; 76(4):628-36. PubMed ID: 4056250
[TBL] [Abstract][Full Text] [Related]
10. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma.
Vathenen AS; Knox AJ; Wisniewski A; Tattersfield AE
Am Rev Respir Dis; 1991 Jun; 143(6):1317-21. PubMed ID: 2048819
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the bronchial response to respiratory heat exchange by increasing doses of terbutaline sulphate.
O'Byrne PM; Morris M; Roberts R; Hargreave FE
Thorax; 1982 Dec; 37(12):913-7. PubMed ID: 6763373
[TBL] [Abstract][Full Text] [Related]
12. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
Harrison TW; Oborne J; Wilding PJ; Tattersfield AE
Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
[TBL] [Abstract][Full Text] [Related]
13. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
[TBL] [Abstract][Full Text] [Related]
14. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Selroos O; Sovijärvi A
N Engl J Med; 1994 Sep; 331(11):700-5. PubMed ID: 8058076
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.
O'Connor BJ; Aikman SL; Barnes PJ
N Engl J Med; 1992 Oct; 327(17):1204-8. PubMed ID: 1357551
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma.
Nichol GM; Nix A; Chung KF; Barnes PJ
Thorax; 1989 Dec; 44(12):1009-14. PubMed ID: 2533410
[TBL] [Abstract][Full Text] [Related]
17. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
18. Effects of pretreatment with inhaled methoxamine on bronchial responses to histamine in asthmatic subjects.
Phan-Puibaraud TT; Regnard J; Monchi M; Dall'Ava-Santucci J; Lockhart A; Dinh-Xuan AT
Eur Respir J; 1995 Jan; 8(1):40-6. PubMed ID: 7744192
[TBL] [Abstract][Full Text] [Related]
19. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction.
Ihre E; Larsson K
Chest; 1990 Jan; 97(1):46-51. PubMed ID: 2136826
[TBL] [Abstract][Full Text] [Related]
20. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.
Crimi N; Polosa R; Pulvirenti G; Magrì S; Santonocito G; Prosperini G; Mastruzzo C; Mistretta A
Thorax; 1995 May; 50(5):505-10. PubMed ID: 7597662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
